Most melanomas are associated with mutational activation of the BRAF gene, and missense mutations of BRAF have been reported to be the oncogenic form in approximately 70% of melanomas, compared to a low frequency of mutations in other human cancers. The gene discussed is BRAF; the disease is cancer.